2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
5
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
6
Irinotecan
5
Fluorouracil
5
Drug Therapy
4
Bevacizumab
4
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Capecitabine
3
5,10-methylenetetrahydrofolic acid
3
pembrolizumab
2
Ocoxin
2
Levoleucovorin
2
Folfox protocol
2
Exercise Test
2
Cyclophosphamide
2
Cetuximab
2
trifluridine tipiracil drug combination
1
sintilimab
1
repotrectinib
1
pralsetinib
1
penpulimab
1
napabucasin
1
lutetium Lu 177 dotatate
1
huachansu
1
guadecitabine
1
golotimod
1
encorafenib
1
copper dotatate CU-64
1
alectinib
1
XELOX
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Diseases
×
S-1 plus cisplatin
×
Clear all
NCT02322593
2021-12-20
SOLAR
Taiho Pharmaceutical Co., Ltd.
Phase 3
Completed
711 enrolled
16 charts